There was one negative, the increased revenue did not translate into increased profits.
Slide 14 paints a very interesting picture.
Revenue + 25% - Good
Gross profit +24% - Good
NPATA + 10% - Not Good
There was a lot of leakage in S & M expenses, R & D (Ok with that - it is needed in their business) G & A and finance (understandable due to VIFOR acquisition).
I suspect that there will be some cost reduction occurring very soon in S & M to get Gross profit translating to NAPTA better.
HT1
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$265.50 |
Change
1.550(0.59%) |
Mkt cap ! $128.5B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $265.88 | $259.33 | $230.1M | 870.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $265.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $265.80 | 79 | 1 |
View Market Depth
| Last trade - 16.12pm 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |